Skip to main content
Premium Trial:

Request an Annual Quote

Steinmetz Joins Board Of Directors of Caliper

Premium

PALO ALTO, Calif.--Michael Steinmetz, managing director of the biotechnology venture capital firm Venture Asset Management, Cambridge, Mass., was elected to the board of directors of the bioinformation technology company Caliper Technologies here. Steinmetz also serves as acting CEO of the new, Munich-based, functional genomics company Genome Pharmaceuticals, and was previously vice-president of preclinical R&D for Hoffmann-LaRoche.

Caliper's chief product is the LabChip, a proprietary microfluidic bioprocessor technology that integrates microfabrication, electronics, software, biology, and chemistry, according to the company. Among LabChips' application are genomics and ultrahigh-throughput experimentation. Steinmetz predicted that the product "will revolutionize the generation and management of biochemical information."

David Lam, Caliper's president and CEO, said the company "will benefit greatly" from Steinmetz's "knowledge and experience in the biopharmaceutical industry and his track record of building strategic alliances." Steinmetz noted that the board appointment "continues a relationship I began with Caliper last year at Hoffmann-La Roche." Among Steinmetz's other accomplishments at the pharmaceutical company, he directed research alliances with such genomics companies as Millennium Pharmaceuticals and Incyte Pharmaceuticals.

Filed under

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.